NIH-funded research R21 grant

Understanding how genetic changes in PLCG2 affect Alzheimer's disease risk

Official title: Deciphering genetics of PLCG2 alternative splicing to understand AD risk

Funded at University of Kentucky · NIH-10889353 · Data updated 2026-11-12

This study is looking at how changes in a specific gene called PLCG2 might affect the risk of developing Alzheimer's disease, with the hope that understanding these genetic factors can help create better treatments for people at risk.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startApril 15, 2024
Project endMarch 31, 2026
Funding year2024
Award (this year)$415,626
NIH project number1R21AG083820-01A1
Project IDNIH-10889353 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a family history of Alzheimer's disease or those who have been genetically tested and identified as having risk variants associated with AD.

Less likely to help

Patients who do not have a genetic predisposition to Alzheimer's disease or those with other forms of dementia unrelated to the genetic factors being studied may not benefit from this research.

What this research studies

This research investigates the genetic factors that influence the risk of developing Alzheimer's disease (AD), focusing specifically on the PLCG2 gene. The study aims to understand how variations in this gene affect its expression and splicing, which may play a crucial role in AD pathology. By examining genetic variants and their impact on PLCG2, researchers hope to uncover new insights into the molecular mechanisms of AD. This could lead to the development of targeted therapies that address these genetic influences.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating Alzheimer's disease by targeting specific genetic mechanisms.

How similar studies have gone: Other research has shown success in identifying genetic factors related to Alzheimer's disease, suggesting that this approach could yield valuable insights.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Estus, Steven — University of Kentucky
  • Study coordinator: Estus, Steven

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.